SPG
60
2
UAL
83
-2
EBAY
42
-2
CI
45
-3
AME
74
-4
LB
30
4
CTSH
60
-3
LEN
50
-2
WDC
37
-3
AAP
35
-9
HST
39
-3
MRO
50
4
FSLR
44
-2
MSFT
46
-11
IBM
47
-3
CB
57
2
BDX
56
10
SYF
86
-6
PLD
45
-5
NSC
53
-4
SPG
60
2
UAL
83
-2
EBAY
42
-2
CI
45
-3
AME
74
-4
LB
30
4
CTSH
60
-3
LEN
50
-2
WDC
37
-3
AAP
35
-9
HST
39
-3
MRO
50
4
FSLR
44
-2
MSFT
46
-11
IBM
47
-3
CB
57
2
BDX
56
10
SYF
86
-6
PLD
45
-5
NSC
53
-4
Financhill
Back

Quest Resource Holding Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
48

QRHC
Quest Resource Holding

Last Price:
6.80
Seasonality Move:
13.68%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
48
Quest Resource Holding (QRHC) is a Sell

Is Quest Resource Holding a Buy, Sell or Hold?

  • The current Quest Resource Holding [QRHC] share price is $6.81. The Score for QRHC is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • QRHC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QRHC Stock Price Chart

What is Quest Resource Holding's stock price today?

  • The Quest Resource Holding share price today is $6.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QRHC is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

QRHC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 29.02 Sell
Chaikin Money Flow: -63287 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.38 - 8.3) Sell
Bollinger Bands (100): (7.84 - 8.8) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

QRHC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.36 Sell
20-day SMA: 7.75 Sell
50-day SMA: 8.15 Sell
200-day SMA: 8.37 Sell
8-day EMA: 7.25 Sell
20-day EMA: 7.62 Sell
50-day EMA: 7.99 Sell
200-day EMA: 8.15 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Quest Resource Holding Earnings Growth & QRHC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.29 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Quest Resource Holding Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):